(Q51742226)

11 April 2018

title

Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. (English)

1 reference

11 April 2018

1 reference

2

1 reference

11 April 2018

author name string

Kyo Young Song

series ordinal

1

1 reference

11 April 2018

Won Sang Park

series ordinal

3

1 reference

11 April 2018

Cho Hyun Park

series ordinal

4

1 reference

11 April 2018

publication date

31 March 2009

1 reference

11 April 2018

Japanese Journal of Clinical Oncology

published in

1 reference

11 April 2018

volume

39

1 reference

11 April 2018

issue

5

1 reference

11 April 2018

page(s)

290-296

1 reference

11 April 2018

Molecular-pathological prognostic factors of gastric cancer: a review

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Molecular markers for gastric adenocarcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

How apoptosis is regulated, and what goes wrong in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Survivin: a bifunctional inhibitor of apoptosis protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Survivin promotes cell proliferation in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Advances in the treatment of patients with gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Recent advances in conventional and molecular prognostic factors for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Targeted therapy by disabling crossroad signaling networks: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Increased expression of survivin in gastric cancer patients and in first degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Prognostic significance and different properties of survivin splicing variants in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Cell division and cell survival in the absence of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Targeting p53 to mitochondria for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP020

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYP020

1 reference

11 April 2018

1 reference

11 April 2018